Global blood culture tests market will reach $9,621.7 million by 2031, growing by 8.2% annually over 2021-2031, driven by the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 84 tables and 87 figures, this 165-page report “Global Blood Culture Tests Market 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Consumables


o Blood Culture Media
o Assay Kits & Reagents
o Blood Culture Accessories

  • Instruments


o Automated Blood Culture Systems
o Supporting Laboratory Equipment

  • Software and Services



Based on Method, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Conventional/Manual Methods
  • Automated Methods



Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Culture-Based Technologies
  • Molecular Technologies


o Microarrays
o Polymerase Chain Reaction (PCR)
o PNA-FISH

  • Proteomics Technology
  • Other Technologies



Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Bacteremia
  • Fungemia
  • Mycobacterial Detection



Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Hospital Laboratories
  • Reference Laboratories
  • Academic Research Laboratories
  • Other End Users



Geographically, the following regions together with the listed national/local markets are fully investigated:

  • North America (U.S., Canada, and Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (UAE, Saudi Arabia, South Africa, Other Nations)


For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioM?rieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)